Magellan Health, Inc. has entered into an agreement to acquire Veridicus Holdings, LLC, a privately held pharmacy benefit management (PBM) organization with a unique set of clinical services and capabilities. Veridicus’ differentiated approach to pharmacy management leverages proprietary analytics and clinical software that integrates pharmacy, medical and lab data to drive targeted interventions resulting in better health outcomes and lower costs for complex patient populations. In addition, Veridicus owns and operates a fully licensed insurance company which is contracted with the Centers for Medicare and Medicaid Services and serves members enrolled in the Medicare Part D Employer Group Waiver Plan program.
“This acquisition will build upon Magellan Rx Management’s clinically oriented approach to PBM (pharmacy benefit management) services with additional capabilities that further amplify our laser focus on improving quality of care and outcomes for the patients we serve, while reining in overall costs for payers,” says Mostafa Kamal, chief executive officer of Magellan Rx Management.
